Galecto CEO Transition and Major Shareholder-Approved Restructuring

Galecto ( (GLTO) ) has provided an announcement.

On February 6, 2026, Galecto’s board decided that Hans T. Schambye would step down as chief executive officer and president, effective 12:01 a.m. Eastern time on February 10, 2026, and he also resigned from the board on February 9, 2026, with the company stating his departure was not due to any disagreement over operations, policies or practices. The board appointed chief operating officer Sherwin Sattarzadeh as interim principal executive officer from the same effective time, while confirming that his existing employment terms remain in place and that his appointment was not the product of any special arrangements or family relationships.

At a special shareholders’ meeting held on February 9, 2026, investors approved the conversion of preferred stock into common stock, an increase in authorized common shares to 500 million, a redomestication of Galecto from Delaware to the Cayman Islands, and new 2026 equity incentive and employee stock purchase plans. Following approval of the conversion proposal and automatic conversion of Series C preferred shares, Galecto reported approximately 43.6 million common shares outstanding as of February 9, 2026, underscoring a significant expansion of its equity base and a shift in its corporate and capital structure that may affect governance, dilution, and future financing flexibility.

The most recent analyst rating on (GLTO) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Galecto stock, see the GLTO Stock Forecast page.

Spark’s Take on GLTO Stock

According to Spark, TipRanks’ AI Analyst, GLTO is a Neutral.

The score is held back primarily by weak fundamentals (no revenue, ongoing losses, and continued cash burn despite improvement) and unattractive earnings-based valuation (negative P/E). Offsetting factors include strong technical momentum (price above key moving averages with positive MACD) and positive corporate developments (Damora acquisition and associated financing extending runway).

To see Spark’s full report on GLTO stock, click here.

More about Galecto

Galecto, Inc. is a biopharmaceutical company focused on developing novel therapeutics, operating as a publicly traded entity with its common stock listed on Nasdaq. The company utilizes preferred stock structures and equity incentive plans as part of its capital formation and employee compensation strategy, reflecting an active approach to financing and governance.

Average Trading Volume: 441,625

Technical Sentiment Signal: Buy

Current Market Cap: $40.35M

Learn more about GLTO stock on TipRanks’ Stock Analysis page.